Tin tức & Cập nhật

Nearly two in three participants in the placebo arm of nonalcoholic steatohepatitis (NASH) randomized clinical trials (RCTs) experience an adverse event (AE), while one in 10 have a serious AE, according to a pooled analysis of studies with NASH placebo.

Treatment with bevantolol hydrochloride (SOM3355) is well tolerated and results in a reduction in chorea among patients with Huntington’s disease (HD), a study has shown.

The use of cloxacillin alone is just as good as the combination of cloxacillin plus fosfomycin in terms of achieving treatment success among hospitalized patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia, according to the results of the open-label, phase IV-III SAFO trial presented at the ECCMID 2023.

The addition of pembrolizumab to standard chemotherapy significantly improves progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, regardless of whether they had mismatch repair-deficient (dMMR) or mismatch repair-proficient (pMMR) disease, according to the NRG-GY018 trial presented at the SGO 2023.

Treatment with the 5-HT1 receptor agonist buspirone in patients with gastroparesis falls short of reducing symptoms including moderate-to-severe early satiety/postprandial fullness, according to a study.

Women with low levels of omega-3 in early pregnancy may lower their risk of early preterm birth by taking supplements, as suggested in a study.